[ASAP] Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel

AI Summary

This article focuses on the formation of amorphous solid dispersions to improve the release performance of racemic and enantiopure praziquantel. The study aims to enhance the solubility and bioavailability of the drug. The use of amorphous solid dispersions is a common strategy in pharmaceutical research to overcome poor drug properties. The findings of this research could have significant implications for drug delivery and therapeutic effectiveness.

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00711

Leave a Reply